Page 118 - Read Online
P. 118

Arisha et al. Vessel Plus 2018;2:14  I  http://dx.doi.org/10.20517/2574-1209.2018.29                                                   Page 15 of 17

               58.  Wańha W, Kawecki D, Roleder T, Morawiec B, Gładysz S, Kowalówka A, Jadczyk T, Adamus B, Pawłowski T, Smolka G, Kaźmierski
                   M, Ochała A, Nowalany-Kozielska E, Wojakowski W. Second-generation drug-eluting stents in the elderly patients with acute coronary
                   syndrome: the in-hospital and 12-month follow-up of the all-comer registry. Aging Clin Exp Res 2017;29:885-93.
               59.  Gayed M, Yadak N, Qamhia W, Daralammouri Y, Ohlow MA. Comorbidities and complications in nonagenarians undergoing coronary
                   angiography and intervention. Int Heart J 2017;58:180-4.
               60.  Lahtela HM, Bah A, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Karjalainen PP, Proietti M, Hartikainen JEK, Lip GYH, Airaksinen
                   KEJ. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS
                   registry. Clin Cardiol 2017;40:1264-70.
               61.  Rubboli A, Schlitt A, Kiviniemi T, Biancari F, Karjalainen PP, Valencia J, Laine M, Kirchhof P, Niemelä M, Vikman S, Lip GYH,
                   Airaksinen KEJ; AFCAS Study Group. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an
                   analysis of the AFCAS registry. Clin Cardiol 2014;37:357-64.
               62.  Sharma R, Hiebert B, Cheung D, Jassal DS, Minhas K. Primary coronary intervention in octogenarians and nonagenarians with ST-
                   segment elevation myocardial infarction: a Canadian single-center perspective. Angiology 2017; doi: 10.1177/0003319717746520.
               63.  Sappa R, Grillo MT, Cinquetti M, Prati G, Spedicato L, Nucifora G, Perkan A, Zanuttini D, Sinagra G, Proclemer A. Short and long-
                   term outcome in very old patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention. Int J
                   Cardiol 2017;249:112-8.
               64.  Bhat FA, Changal KH, Raina H, Tramboo NA, Rather HA. Transradial versus transfemoral approach for coronary angiography and
                   angioplasty - a prospective, randomized comparison. BMC Cardiovasc Disord 2017;17:23.
               65.  Anjum I, Khan MA, Aadil M, Faraz A, Farooqui M, Hashmi A. Transradial vs. transfemoral approach in cardiac catheterization: a
                   literature review. Cureus 2017;9:e1309.
               66.  He PY, Yang YJ, Qiao SB, Xu B, Yao M, Wu YJ, Yuan JQ, Chen J, Liu HB, Dai J, Tang XR, Wang Y, Li W, Gao RL. A comparison of
                   transradial and transfemoral approaches for percutaneous coronary intervention in elderly patients based on a propensity score analysis.
                   Angiology 2015;66:448-55.
               67.  Tammam K, Ikari Y, Yoshimachi F, Saito F, Hassan W. Impact of transradial coronary intervention on bleeding complications in
                   octogenarians. Cardiovasc Interv Ther 2017;32:18-23.
               68.  Lee HW, Cha KS, Ahn J, Choi JC, Oh JH, Choi JH, Lee HC, Yun E, Jang HY, Choi JH, Hong TJ, Jeong MH, Ahn Y, Chae SC, Kim
                   YJ; Korea Acute Myocardial Infarction Registry Investigators. Comparison of transradial and transfemoral coronary intervention in
                   octogenarians with acute myocardial infarction. Int J Cardiol 2016;202:419-24.
               69.  Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS,
                   Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary
                   artery. N Engl J Med 2003;349:1315-23.
               70.  Tian W, Mahmoudi M, Lhermusier T, Kiramijyan S, Chen F, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. The
                   influence of advancing age on implantation of drug-eluting stents. Catheter Cardiovasc Interv 2016;88:516-21.
               71.  Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT,
                   Finn AV, Kim HS, Kubica J, Suryapranata H, Aprami TM, Di Pasquale G, von Birgelen C, Kedhi E. Safety and efficacy outcomes of
                   first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice:
                   comprehensive network meta-analysis. BMJ 2013;347:f6530.
               72.  El-Hayek G, Messerli F, Bangalore S, Hong MK, Herzog E, Benjo A, Tamis-Holland JE. Meta-analysis of randomized clinical trials
                   comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents. Am J Cardiol 2014;114:236-42.
               73.  Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot
                   P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE
                   Investigators. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 2015;373:2038-47.
               74.  Morice MC, Talwar S, Gaemperli O, Richardt G, Eberli F, Meredith I, Zaman A, Fajadet J, Copt S, Greene S, Urban P. Drug-coated
                   versus bare-metal stents for elderly patients: a predefined sub-study of the LEADERS FREE trial. Int J Cardiol 2017;243:110-5.
               75.  de Belder A, de la Torre Hernandez JM, Lopez-Palop R, O’Kane P, Hernandez Hernandez F, Strange J, Gimeno F, Cotton J, Diaz
                   Fernandez JF, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz JA, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D;
                   XIMA Investigators. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA
                   Trial (Xience or Vision Stents for the Management of Angina in the Elderly). J Am Coll Cardiol 2014;63:1371-5.
               76.  Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrié D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez
                   JF, Brugaletta S, Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR; SENIOR
                   investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet
                   Lond Engl 2018;391:41-50.
               77.  Daugherty SL, Thompson LE, Kim S, Rao SV, Subherwal S, Tsai TT, Messenger JC, Masoudi FA. Patterns of use and comparative
                   effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study
                   from the National Cardiovascular Data Registry. J Am Coll Cardiol 2013;61:2070-8.
               78.  Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, Cohen DJ, Messenger JC, Rumsfeld JS; National Cardiovascular
                   Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing
                   percutaneous coronary intervention. JAMA 2010;303:2156-64.
               79.  Khambatta S, Othman H, Seth M, Lalonde T, Rosman HS, Gurm HS, Mehta RH; Blue Cross Blue Shield of Michigan Cardiovascular
                   Consortium (BMC2) Investigators. Association of bleeding avoidance strategies with age-related bleeding and in-hospital mortality in
   113   114   115   116   117   118   119   120   121   122   123